Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tateishi, Ryosuke ^a   Shiina, Shuichiro ^a   Akahane, Masaaki ^a   Sato, Jiro ^a   Kondo, Yuji ^a   Masuzaki, Ryota ^a   Nakagawa, Hayato ^a   Asaoka, Yoshinari ^a   Goto, Tadashi ^a   Otomo, Kuni ^a   Omata, Masao ^b   Yoshida, Haruhiko ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yamanashi Prefectural Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876071057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059040     Document Type: Article

References (45)

1. Bruix J, Sherman M, (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
2. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, et al. (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101: 796-802.
3. Makuuchi M, Hasegawa H, Yamazaki S, (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161: 346-350.
4. Castaing D, Garden OJ, Bismuth H, (1989) Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg 210: 20-23.
5. Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, et al. (1996) Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 223: 297-302.
6. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, et al. (1999) Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 86: 1032-1038.
7. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, et al. (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131: 311-317.
8. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, et al. (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242: 252-259.
9. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, et al. (1990) Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 5: 616-626.
10. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, et al. (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197: 101-108.
11. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, et al. (1993) Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 160: 1023-1028.
12. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, et al. (1999) Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 85: 1694-1702.
13. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, et al. (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167: 759-768.
14. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE, (1999) Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 353: 1676-1677.
15. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, et al. (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210: 655-661.
16. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P, (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232: 381-391.
17. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, et al. (2005) Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242: 36-42.
18. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82-89.
19. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328.
20. N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, et al. (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50: 1475-1483.
21. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, et al. (2003) Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26: 142-147.
22. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103: 1201-1209.
23. Teratani T, Yoshida H, Shiina S, Obi S, Sato S, et al. (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43: 1101-1108.
24. Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, et al. (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30: 889-893.
25. Liver Cancer Study Group of Japan (2003) General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Second English Edition. Tokyo: Kasahara.
26. Couinaud C (1954) Lobes et segments hepatiques. Note sur l'architecture anatomique et chirurgicale du foie: Presse Med. pp. 709-711.
27. Nakagawa K, Yamashita H, Shiraishi K, Nakamura N, Tago M, et al. (2005) Radiation therapy for portal venous invasion by hepatocellular carcinoma. World J Gastroenterol 11: 7237-7241.
28. Obi S, Yoshida H, Toune R, Unuma T, Kanda M, et al. (2006) Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106: 1990-1997.
29. Cohen J, (1960) A Coefficient of Agreement for Nominal Scales. Educational and Psychological Measurement 20: 37-46.
30. Gray R, (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 16: 1141-1154.
31. Muller HG, Wang JL, (1994) Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics 50: 61-76.
32. Sakon M, Umeshita K, Nagano H, Eguchi H, Kishimoto S, et al. (2000) Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 135: 1456-1459.
33. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, et al. (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143: 469-475.
34. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, et al. (2000) Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology 32: 1216-1223.
35. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, et al. (1993) Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71: 19-25.
36. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207.
37. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, et al. (2006) Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 44: 1543-1554.
38. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10: 35-43.
39. Plessier A, Codes L, Consigny Y, Sommacale D, Dondero F, et al. (2004) Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl 10: S86-90.
40. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, et al. (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245: 36-43.
41. Nagasue N, Kohno H, Hayashi T, Uchida M, Ono T, et al. (1996) Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 83: 127-131.
42. Poon RT, Fan ST, Lo CM, Liu CL, Wong J, (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216-222.
43. Nakajima Y, Ko S, Kanamura T, Nagao M, Kanehiro H, et al. (2001) Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192: 339-344.
44. Yamashiki N, Tateishi R, Yoshida H, Shiina S, Teratani T, et al. (2005) Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation. Liver Transpl 11: 508-514.
45. Liang HH, Chen MS, Peng ZW, Zhang YJ, Zhang YQ, et al. (2008) Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol 15: 3484-3493.